Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -592,593 | -1,836,642 | -231,647 | -129,242 | -74,778 |
| Depreciation Amortization | 8,940 | 29,076 | 21,073 | 12,794 | 5,629 |
| Accounts receivable | -34,928 | -114,094 | -28,670 | -6,479 | -9,541 |
| Accounts payable and accrued liabilities | 26,250 | -2,247 | -2,771 | -7,321 | 516 |
| Other Working Capital | -13,892 | -61,537 | 30,805 | 5,560 | 3,073 |
| Other Operating Activity | 586,325 | 1,731,626 | 122,933 | 41,646 | 26,970 |
| Operating Cash Flow | $-19,898 | $-253,818 | $-88,277 | $-83,042 | $-48,131 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,522 | -56,521 | -51,407 | -45,969 | -21,935 |
| Net Acquisitions | N/A | -12,040 | -21,382 | -1,210 | -1,210 |
| Purchase Of Investment | -3,691 | -5,000 | -5,000 | N/A | N/A |
| Other Investing Activity | -28,772 | 304 | 304 | 202 | 99 |
| Investing Cash Flow | $-35,985 | $-73,257 | $-77,485 | $-46,977 | $-23,046 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -286 | -1,123 | -764 | -448 | -285 |
| Common Stock Issued | 75 | 167 | 41 | 39 | 27 |
| Common Stock Repurchased | N/A | -24,998 | -24,998 | N/A | N/A |
| Other Financing Activity | -981 | 1,560,099 | 1,570,909 | -2,147 | -175 |
| Financing Cash Flow | $-1,192 | $1,534,145 | $1,545,188 | $-2,556 | $-433 |
| Exchange Rate Effect | -8 | -19 | -8 | 0 | 0 |
| Beginning Cash Position | 1,550,004 | 385,877 | 385,877 | 380,801 | 379,738 |
| End Cash Position | 1,492,921 | 1,592,928 | 1,765,295 | 248,226 | 308,128 |
| Net Cash Flow | $-57,083 | $1,207,051 | $1,379,418 | $-132,575 | $-71,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,898 | -253,818 | -88,277 | -83,042 | -48,131 |
| Capital Expenditure | -3,580 | -56,521 | -51,407 | -45,969 | -21,935 |
| Free Cash Flow | -23,478 | -310,339 | -139,684 | -129,011 | -70,066 |